{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T20:17:37Z","timestamp":1791490657493,"version":"4.3.4"},"reference-count":48,"publisher":"Frontiers Media SA","content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Cardiovasc. Med."],"DOI":"10.3389\/fcvm.2016.00003","type":"journal-article","created":{"date-parts":[[2016,2,23]],"date-time":"2016-02-23T14:22:55Z","timestamp":1456237375000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":79,"title":["Timeline of History of Hypertension Treatment"],"prefix":"10.3389","volume":"3","author":[{"given":"Mohammad G.","family":"Saklayen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neeraj V.","family":"Deshpande","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2016,2,23]]},"reference":[{"key":"B1","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1177\/014107689108401019","article-title":"From blood pressure to hypertension: the history of research","volume":"84","author":"Esunge","year":"1991","journal-title":"J R Soc Med"},{"key":"B2","doi-asserted-by":"publisher","first-page":"1488","DOI":"10.1038\/ki.1996.209","article-title":"Frederick Akbar Mahomed and his role in the description of hypertension at Guy\u2019s Hospital","volume":"49","author":"Cameron","year":"1996","journal-title":"Kidney Int"},{"key":"B3","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1161\/01.HYP.19.2.212","article-title":"Frederic Akbar Mahomed","volume":"19","author":"O\u2019Rourke","year":"1992","journal-title":"Hypertension"},{"key":"B4","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1177\/003591577707001112","article-title":"A short history of blood pressure measurement","volume":"70","author":"Booth","year":"1977","journal-title":"Proc Roy Soc Med"},{"key":"B5","doi-asserted-by":"publisher","first-page":"999","DOI":"10.1016\/S0140-6736(13)61752-3","article-title":"The Framingham heart study and the epidemiology of cardiovascular disease: a historical perspective","volume":"383","author":"Mahmood","year":"2014","journal-title":"Lancet"},{"key":"B6","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1001\/jama.1970.03180020021004","article-title":"Epidemiologic assessment of the role of blood pressure in stroke","volume":"214","author":"Kannel","year":"1970","journal-title":"JAMA"},{"issue":"1","key":"B7","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1378\/chest.56.1.43","article-title":"Blood pressure and risk of coronary heart disease: the Framingham study","volume":"56","author":"Kannel","year":"1969","journal-title":"Dis Chest"},{"key":"B8","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1001\/archinte.1960.03860170005002","article-title":"Antihypertensive drug therapy: an appraisal","volume":"115","author":"Goldring","year":"1965","journal-title":"Arch Intern Med"},{"key":"B9","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1111\/j.1524-6175.2006.05836.x","article-title":"Historical perspective on management of hypertension","volume":"8","author":"Moser","year":"2006","journal-title":"J Clin Hypertens"},{"key":"B10","first-page":"582","article-title":"Streptomycin treatment of tuberculous meningitis","volume":"1","author":"Medical Research Council","year":"1948","journal-title":"Lancet"},{"key":"B11","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1001\/jama.1958.02990020025004","article-title":"Treatment of essential hypertension with chlorothiazide (diuril); its use alone and combined with other antihypertensive agents","volume":"166","author":"Freis","year":"1958","journal-title":"JAMA"},{"key":"B12","doi-asserted-by":"publisher","first-page":"1813","DOI":"10.1126\/science.2063193","article-title":"Blood pressure control-special role of kidneys and body fluid","volume":"252","author":"Guyton","year":"1991","journal-title":"Science"},{"key":"B13","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1161\/01.HYP.16.4.472","article-title":"Reminiscences of the Veterans Administration Trial of the treatment of hypertension","volume":"16","author":"Freis","year":"1990","journal-title":"Hypertension"},{"key":"B14","doi-asserted-by":"publisher","first-page":"522","DOI":"10.1161\/HYPERTENSIONAHA.111.177766","article-title":"Historical trends and milestones in hypertension research: a model of the process of translational research","volume":"58","author":"Kotchen","year":"2011","journal-title":"Hypertension"},{"key":"B15","doi-asserted-by":"publisher","first-page":"1028","DOI":"10.1001\/jama.1967.03130240070013","article-title":"Effects of treatment on morbidity in hypertension. Results in patients with diastolic blood pressures averaging 115 through 129 mm Hg","volume":"202","author":"Veterans Administration Cooperative Study Group on Anti-hypertensive Agents","year":"1967","journal-title":"JAMA"},{"key":"B16","doi-asserted-by":"publisher","first-page":"1143","DOI":"10.1001\/jama.213.7.1143","article-title":"Effects of treatment on morbidity in hypertension. II. Results in patients with diastolic blood pressure averaging 90 through 114 mm Hg","volume":"213","author":"Veterans Administration Cooperative Study Group on Anti-hypertensive Agents","year":"1970","journal-title":"JAMA"},{"key":"B17","doi-asserted-by":"publisher","first-page":"2562","DOI":"10.1001\/jama.1979.03300230018021","article-title":"Five-year findings of the hypertension detection and follow-up program. I. Reduction in mortality of persons with high blood pressure, including mild hypertension","volume":"242","author":"Hypertension Detection and Follow-Up Program Cooperative Group","year":"1979","journal-title":"JAMA"},{"key":"B18","doi-asserted-by":"publisher","first-page":"1465","DOI":"10.1001\/jama.1982.03330120023025","article-title":"Risk factor changes and mortality results","volume":"248","author":"Multiple Risk Factor Intervention Trial","year":"1982","journal-title":"JAMA"},{"key":"B19","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1136\/bmj.291.6488.97","article-title":"MRC trial of treatment of mild hypertension: principal results","volume":"291","author":"Medical Research Council Working Party","year":"1985","journal-title":"Br Med J"},{"key":"B20","first-page":"S642","article-title":"Influence of antihypertensive drug treatment on morbidity and mortality in patients over the age of 60 years. EWPHE results: sub-group analysis based on entry stratification","volume":"4","author":"Amery","year":"1986","journal-title":"J Hypertens"},{"key":"B21","doi-asserted-by":"publisher","first-page":"1552","DOI":"10.1136\/bmj.298.6687.1552","article-title":"Relation between mortality and treated blood pressure in elderly patients with hypertension: report of the European working party on high blood pressure in the elderly","volume":"298","author":"Staessen","year":"1989","journal-title":"BMJ"},{"key":"B22","doi-asserted-by":"publisher","first-page":"3255","DOI":"10.1001\/jama.265.24.3255","article-title":"Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension. Final results of the systolic hypertension in the elderly program (SHEP)","volume":"265","author":"SHEP Cooperative Research Group","year":"1991","journal-title":"JAMA"},{"key":"B23","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1001\/jama.1993.03510060059034","article-title":"Treatment of mild hypertension study: final results","volume":"270","author":"Neaton","year":"1993","journal-title":"JAMA"},{"key":"B24","doi-asserted-by":"publisher","first-page":"1117","DOI":"10.1056\/NEJM199704173361601","article-title":"A clinical trial of the effects of dietary patterns on blood pressure: DASH collaborative research group","volume":"16","author":"Appel","year":"1997","journal-title":"N Engl J Med"},{"key":"B25","doi-asserted-by":"publisher","first-page":"850","DOI":"10.1016\/S0140-6736(97)02264-2","article-title":"Double-blind randomized trial of modest salt restriction in older people","volume":"350","author":"Cappucio","year":"1997","journal-title":"Lancet"},{"key":"B26","doi-asserted-by":"publisher","first-page":"1755","DOI":"10.1016\/S0140-6736(98)04311-6","article-title":"Effects of intensive blood pressure lowering and low dose aspirin in patients with hypertension: principal results of the hypertension optimal treatment (HOT) randomized trial","volume":"351","author":"Hansson","year":"1998","journal-title":"Lancet"},{"key":"B27","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1136\/bmj.317.7160.703","article-title":"Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38","volume":"317","author":"UK Prospective Diabetes Study Group","year":"1998","journal-title":"BMJ"},{"key":"B28","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1136\/bmj.317.7160.713","article-title":"Efficacy of atenolol and captopril in reducing risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 39","volume":"317","author":"UK Prospective Diabetes Study Group","year":"1998","journal-title":"BMJ"},{"key":"B29","doi-asserted-by":"publisher","first-page":"2421","DOI":"10.1001\/jama.288.19.2421","article-title":"Effect of blood pressure lowering and antihypertensive drug class on progression of hypertensive kidney disease results from the AASK trial","volume":"288","author":"Wright","year":"2002","journal-title":"JAMA"},{"key":"B30","doi-asserted-by":"publisher","first-page":"2981","DOI":"10.1001\/jama.288.23.2981","article-title":"Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic: the antihypertension and lipid-lowering treatment to prevent heart attack trial (ALLHAT)","volume":"288","author":"ALLHAT Officers and Coordinators for the ALLHAT Collaborative Research Group","year":"2002","journal-title":"JAMA"},{"key":"B31","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1056\/NEJMoa021716","article-title":"A comparison of outcomes with angiotensin-converting-enzyme inhibitors and diuretics for hypertension in the elderly","volume":"348","author":"Wing","year":"2003","journal-title":"N Engl J Med"},{"key":"B32","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1016\/S0140-6736(05)67185-1","article-title":"Prevention of cardiovascular events with an antihypertensive regimen of amlodipine adding perindopril as required versus atenolol adding bendroflumethazide as required, in the Anglo Scandinavian cardiac outcomes trial-blood pressure lowering arm (ASCOT-BPLA): a multicentre randomised controlled trial","volume":"366","author":"Dahlof","year":"2005","journal-title":"Lancet"},{"key":"B33","doi-asserted-by":"publisher","first-page":"1213","DOI":"10.1161\/CIRCULATIONAHA.105.595496","article-title":"Differential impact of blood pressure lowering drugs on central aortic pressure and clinical outcomes principal results of the conduit artery function evaluation (CAFE) study","volume":"113","author":"CAFE Investigators","year":"2006","journal-title":"Circulation"},{"key":"B34","doi-asserted-by":"publisher","first-page":"1887","DOI":"10.1056\/NEJMoa0801369","article-title":"Treatment of hypertension in patients 80 years of age or older","volume":"358","author":"Beckett","year":"2008","journal-title":"N Engl J Med"},{"issue":"23","key":"B35","doi-asserted-by":"publisher","first-page":"2417","DOI":"10.1056\/NEJMoa0806182","article-title":"Benazepril plus amlodipine or hydrochlorothiazide for hypertension in high-risk patients","volume":"359","author":"Jamerson","year":"2008","journal-title":"N Engl J Med"},{"key":"B36","doi-asserted-by":"publisher","first-page":"1575","DOI":"10.1056\/NEJMoa1001286","article-title":"Effects of blood pressure control in type 2 diabetes mellitus","volume":"362","author":"ACCORD Study Group","year":"2010","journal-title":"N Engl J Med"},{"issue":"14","key":"B37","doi-asserted-by":"publisher","first-page":"1279","DOI":"10.1056\/NEJMoa1200303","article-title":"Primary prevention of cardiovascular disease with a Mediterranean diet","volume":"368","author":"Estruch","year":"2013","journal-title":"N Engl J Med"},{"key":"B38","doi-asserted-by":"publisher","first-page":"2103","DOI":"10.1056\/NEJMoa1511939","article-title":"A randomized trial of intensive versus standard blood-pressure control","volume":"373","author":"SPRINT Research Group","year":"2015","journal-title":"N Engl J Med"},{"key":"B39","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1038\/nm.1960","article-title":"Macrophage regulate salt-dependent volume and blood pressure by a vascular endothelial growth factor-C-dependent buffering mechanism","volume":"15","author":"Machnik","year":"2009","journal-title":"Nat Med"},{"key":"B40","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1161\/HYPERTENSIONAHA.109.143339","article-title":"Mononuclear phagocyte system depletion blocks interstitial tonicity-\u00adresponsive enhancer binding protein\/vascular endothelial growth factor C expression and induces salt-sensitive hypertension in rats","volume":"55","author":"Machnik","year":"2011","journal-title":"Hypertension"},{"key":"B41","doi-asserted-by":"publisher","first-page":"4234","DOI":"10.1172\/JCI77766","article-title":"Is hypertension an autoimmune disease?","volume":"124","author":"Pober","year":"2014","journal-title":"J Clin Invest"},{"key":"B42","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1161\/HYPERTENSIONAHA.114.03340","article-title":"In search of the T cell involved in hypertension and target organ damage","volume":"64","author":"Guzik","year":"2014","journal-title":"Hypertension"},{"key":"B43","doi-asserted-by":"publisher","first-page":"1331","DOI":"10.1161\/HYPERTENSIONAHA.115.05315","article-title":"Gut dysbiosis is linked to hypertension","volume":"65","author":"Yang","year":"2015","journal-title":"Hypertension"},{"key":"B44","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/j.jash.2008.11.001","article-title":"Flavanols, the kuna, cocoa consumption and nitric oxide","volume":"3","author":"Hollenberg","year":"2009","journal-title":"J Am Soc Hypertens"},{"key":"B45","doi-asserted-by":"publisher","first-page":"1398","DOI":"10.1161\/HYPERTENSIONAHA.109.147892","article-title":"(-)-Epicatechin activation of endothelial cell endothelial nitric oxide synthase, nitric oxide and related signaling pathways","volume":"55","author":"Ramirez-Sanchez","year":"2010","journal-title":"Hypertension"},{"key":"B46","doi-asserted-by":"publisher","first-page":"75","DOI":"10.3389\/fphys.2015.00075","article-title":"A clinician\u2019s perspective of the role of renal sympathetic nerves in hypertension","volume":"6","author":"Briasoulis","year":"2015","journal-title":"Front Physiol"},{"key":"B47","doi-asserted-by":"publisher","first-page":"931","DOI":"10.1161\/HYPERTENSIONAHA.114.04076","article-title":"Changing relationship among office, ambulatory and home blood pressure with increasing age\u2009\u2013\u2009a neglected issue","volume":"64","author":"Stergiou","year":"2014","journal-title":"Hypertension"},{"key":"B48","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1002\/sim.4780030421","article-title":"Why do we need some large, simple randomized trials?","volume":"3","author":"Yusuf","year":"1984","journal-title":"Stat Med"}],"container-title":["Frontiers in Cardiovascular Medicine"],"original-title":[],"deposited":{"date-parts":[[2023,8,17]],"date-time":"2023-08-17T00:17:48Z","timestamp":1692231468000},"score":1,"resource":{"primary":{"URL":"http:\/\/journal.frontiersin.org\/Article\/10.3389\/fcvm.2016.00003\/abstract"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,2,23]]},"references-count":48,"URL":"https:\/\/doi.org\/10.3389\/fcvm.2016.00003","relation":{},"ISSN":["2297-055X"],"issn-type":[{"value":"2297-055X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,2,23]]}}}